Mangalam Drugs & Organics (BOM:532637) Debt-to-Equity : N/A (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Mangalam Drugs & Organics Debt-to-Equity?

Mangalam Drugs & Organics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0 Mil. Mangalam Drugs & Organics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0 Mil. Mangalam Drugs & Organics's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₹0 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Mangalam Drugs & Organics's Debt-to-Equity or its related term are showing as below:

BOM:532637' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.5 Med: 0.67 Max: 2.43
Current: 0.73

During the past 13 years, the highest Debt-to-Equity Ratio of Mangalam Drugs & Organics was 2.43. The lowest was 0.50. And the median was 0.67.

BOM:532637's Debt-to-Equity is ranked worse than
77.21% of 847 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs BOM:532637: 0.73

Mangalam Drugs & Organics Debt-to-Equity Historical Data

The historical data trend for Mangalam Drugs & Organics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangalam Drugs & Organics Debt-to-Equity Chart

Mangalam Drugs & Organics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

0.50

0.53

0.58

0.73

Mangalam Drugs & Organics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.58	N/A	0.67	N/A	0.73

Competitive Comparison of Mangalam Drugs & Organics's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Mangalam Drugs & Organics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mangalam Drugs & Organics's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mangalam Drugs & Organics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Mangalam Drugs & Organics's Debt-to-Equity falls into.

Mangalam Drugs & Organics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Mangalam Drugs & Organics's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(800.046	+	184.879)	/	1357.93
	=	0.73

Mangalam Drugs & Organics's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0
	=	N/A

Mangalam Drugs & Organics (BOM:532637) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Mangalam Drugs & Organics Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Mangalam Drugs & Organics's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Mangalam Drugs & Organics (BOM:532637) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (BOM:532637) » Definitions » Debt-to-Equity

Traded in Other Exchanges

MANGALAM:India

Address

239, P. D’Mello Road, Rupam Building, 3rd Floor, Near General Post Office, Mumbai, MH, IND, 400001

Website

https://www.mangalamdrugs.com

Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. It is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise of sales in the Indian and overseas markets.

Mangalam Drugs & Organics (BOM:532637) Headlines

No Headlines